Related by context. All words. (Click for frequent words.) 72 Archexin 72 Myocet 70 IMA# 70 oral prodrug 70 Bioral 70 successfully commercialize Iluvien 69 OvaRex R 69 CRMD# 69 Civacir 69 rxRNA 69 Surfaxin LS 69 Panzem R NCD 69 Evoltra ® 69 prostone 69 ZEVALIN ® 69 DPX Survivac 68 PHX# 68 selective immunoproteasome inhibitor 68 tubulin inhibitor 68 candidate deforolimus 68 metaglidasen 68 therapeutic monoclonal antibody 68 TBC# 68 liposomal formulation 68 Onconase 68 drug ISA# 68 pharmacokinetic PK study 68 AAG geldanamycin analog 68 mertansine 68 trastuzumab DM1 T DM1 68 novel oral anticoagulant 68 BrachySil TM 68 Elagolix 68 Xcytrin R 67 Initiate Clinical Trial 67 PDE4 inhibitor 67 OHR/AVR# 67 Personalized Immunotherapy 67 Pazopanib 67 IMiDs 67 Allovectin 7 67 Solazed TM 67 Nanobody 67 UltiMAb 67 leading oral taxane 67 BEMA Granisetron 67 cancer immunotherapies 67 RECOTHROM R 67 motexafin gadolinium Injection 67 therapeutic monoclonal antibodies 67 FOLOTYN ® 67 JAK inhibitor 67 LEVADEX ™ 67 HuMax TAC 67 MAGE A3 ASCI 67 deforolimus 67 Targeted Chemotherapy 67 Azedra 67 TOCOSOL Paclitaxel 67 Exelixis compounds 67 vosaroxin 67 L BLP# 67 Fludara ® 67 BrachySil 67 Zingo TM 67 MOZOBIL 66 Clonicel 66 highly selective adenosine 66 ospemifene 66 Aganocide 66 Panzem 66 Iluvien ® 66 torezolid phosphate 66 subcutaneous formulation 66 Telatinib 66 HCV protease inhibitors 66 TOCOSOL Camptothecin 66 Anavex #-# 66 Micromet BiTE 66 luliconazole 66 Mipomersen 66 Romidepsin 66 Tesetaxel 66 PI3K/Akt pathway inhibitor 66 oral picoplatin 66 anticoagulant reversing agent 66 LymphoStat B TM 66 MOVIPREP R 66 CCR9 antagonist 66 TOCOSOL 66 OvaRex ® MAb 66 Captisol enabled 66 EndoTAG TM 66 DU #b 66 midstage trials 66 including eniluracil ADH 66 Nanobody ® 66 adrenergic regulation 66 docetaxel Taxotere ® 66 P#X# antagonist 66 CINQUIL 66 TELINTRA 66 Adnectin 66 epothilone 66 GLP toxicology studies 66 optical biosensors 66 THALOMID 66 SILENOR 66 PrevOnco 66 glucokinase activator 66 BiDil XR 66 molecular imaging radiopharmaceutical 66 trastuzumab DM1 66 SinuNase ™ 66 SYCREST 66 Troxatyl 66 intranasal delivery 66 MKC# MT 66 Fodosine 66 Marqibo TM 66 LibiGel ® 66 PREOS R 66 Bioral Amphotericin B. 66 Phase IIb clinical trials 65 Genz # 65 SinuNase TM 65 Adentri 65 PORxin TM platforms 65 Onalta ™ 65 Allovectin 7 r 65 Angiocept 65 SPL# Gel vaginal microbicide 65 PEG SN# 65 GRNVAC1 65 CRLX# 65 selective estrogen receptor modulator 65 PRT# 65 acetonide FA 65 isoform selective 65 Proquin XR 65 ruxolitinib 65 eTag assays 65 HuCAL antibodies 65 BCR ABL inhibitors 65 CDP# 65 HSP# inhibitor 65 SNALP technology 65 Cancidas 65 OncoVEX 65 siRNA therapeutics 65 Fortical R 65 ZEGERID Capsules 65 candidate TNFerade biologic 65 Nektar pulmonary 65 histamine dihydrochloride 65 HepeX B 65 MyVax R 65 investigational therapies 65 lucinactant 65 Plicera 65 acyclovir Lauriad R 65 KNS # 65 Nanobody R 65 Captisol ® 65 Xanafide 65 Zemplar Capsules 65 Exherin TM 65 topical dermatology 65 TRISENOX 65 intranasal formulation 65 proteasome inhibitor 65 novel histone deacetylase 65 tiapamil 65 Cand5 65 Pertuzumab 65 immunotherapeutic vaccine 65 AzaSite Plus 65 HCV protease inhibitor 65 TLK# 65 bardoxolone 65 selective orally bioavailable 65 Hemopurifier ® 65 CYT# potent vascular disrupting 65 Saforis 65 TRISENOX ® 65 Icatibant 65 OLEPTRO 65 GALNS 65 Emezine 65 phase IIb clinical 65 TELINTRA R 65 SEPET TM 65 ALN PCS 65 vascular disrupting agents 65 INT# [002] 65 VersaFilm 65 Nexavar ® 65 CCR5 antagonist 65 Zipsor 65 investigational pan BCR 65 COREG CR 65 NeuroSTAT ® 65 CCX# 65 generation purine nucleoside 65 Ophena TM 65 Celator 65 anticancer compound 65 Kosan dependence 65 Urocidin 65 Intravenous CP 65 zanolimumab 65 Tarceva TM 65 PNP inhibitor 65 Spiegelmer ® 65 MEK inhibitors 65 Relivar 65 AMPK activators 65 CINTREDEKIN BESUDOTOX 65 Vidaza R 65 OncoGel 65 Actimmune ® 65 OMNARIS Nasal Spray 65 CIP TRAMADOL ER 65 Zensana TM 65 Poly ICR 65 SAR# [002] 65 AEG# 65 Vaccinex 65 Alocrest 65 SURFAXIN 65 oral salmon calcitonin 65 GIPET 65 NovaBay Aganocide compounds 65 candidate CRLX# 65 renin inhibitor 64 Daclizumab 64 Phase #/#a 64 CobaCyte 64 hypoxia activated prodrug 64 forodesine 64 Trastuzumab DM1 64 tezampanel NGX# 64 YONDELIS 64 Novosom 64 inhaled prostacyclin 64 tezampanel 64 personalized immunotherapy 64 Bioral ® 64 R#/MEM # 64 UPLYSO 64 FUSILEV ® 64 Oasmia 64 ZYFLO CR 64 miRNA therapeutics 64 Insegia 64 VEGF inhibitor 64 personalized cellular immunotherapy 64 novel VDA molecule 64 Synerx 64 lomitapide 64 SNT MC# 64 2 inhibitor CYT# 64 PANVAC VF 64 fusion enhancers 64 DOS# 64 Initiates Phase II 64 JAK inhibitors 64 MKC# MKC# PP 64 KIACTA ™ 64 anti emetic therapy 64 Aurexis 64 registrational trial 64 lumiliximab 64 CBLC# 64 candidate epratuzumab 64 oral ridaforolimus 64 XL# XL# XL# XL# 64 lapatinib Tykerb 64 tolevamer 64 Sular formulation 64 FACTIVE R gemifloxacin 64 Octreotide 64 Anticalin 64 Virulizin ® 64 Quinamed 64 AERx iDMS 64 investigational humanized monoclonal antibody 64 #D#C# 64 EpiCeram 64 VISICOL R 64 multicenter Phase III 64 Teflaro 64 PNT# 64 IL# PE#QQR 64 BENLYSTA ® 64 Phase #b/#a clinical 64 Fentanyl Taifun 64 Diamyd R 64 Biochronomer 64 Retacrit 64 TPI ASM8 64 Syncria 64 5 HT3 antagonist 64 Cleviprex TM clevidipine 64 ADP receptor antagonist 64 TIMERx 64 reslizumab 64 monoclonal antibody therapeutics 64 casopitant 64 Zenpep 64 anti infective treatments 64 MAXY VII 64 QTinno TM 64 HuMax CD4 64 Annamycin 64 CVac 64 REMINYL ® 64 intranasal insulin product 64 YONDELIS R 64 omacetaxine 64 Onco TCS 64 Locteron ® 64 Nanobodies 64 injectable formulations 64 Asentar 64 LEP ETU 64 Oglemilast 64 R sorafenib tablets 64 Cardio Vascu Grow 64 Locked Nucleic Acid LNA 64 PrevOnco ™ 64 oral proteasome inhibitor 64 StemEx R 64 AzaSite Xtra 64 Tykerb lapatinib 64 Aviptadil 64 Rotarix ® 64 ERYtech Pharma 64 custirsen 64 Novolimus 64 sumatriptan DosePro 64 Vidaza azacitidine 64 Chemophase 64 targeted radiotherapeutic 64 Loramyc R 64 PDE# inhibitors 64 immatics 64 Azedra TM 64 Lumacan 64 ABL inhibitor 64 EOquin 64 AQ4N 64 Isis antisense 64 gepirone ER 64 Sopherion 64 Orapred ODT 64 obatoclax 64 Lucanix R 64 RLY# 64 DCCR 64 omacetaxine mepesuccinate 64 non nucleoside HCV 64 oral antiviral 64 virus HCV protease inhibitor 64 EGS# 64 candidate XP# 64 VitiGam 64 Panzem R 64 apricitabine ATC 64 OMNARIS HFA 64 Lipofen 64 Sebivo 64 adipiplon 64 Allovectin 7 R 64 BRAF inhibitors 64 Anidulafungin 64 topical formulations 64 amrubicin 64 VitiGam TM 64 HGS# 64 Zavesca r 64 orBec 64 small molecule PEGylation 64 faropenem 64 Aflibercept 64 Traficet EN 64 anticancer therapeutics 63 systemic RNAi 63 Bezielle 63 PSMA ADC 63 multi kinase inhibitor 63 Pyridorin 63 omega interferon 63 NYSE Amex PTN 63 Onalta 63 neratinib 63 Zerenex 63 DXL# 63 dutogliptin 63 LEUKINE 63 Phase Ib study 63 AeroLEF TM 63 alvespimycin 63 vemurafenib 63 HyACT 63 JAK1 63 aerosolized AAT 63 LentiVector 63 Pruvel 63 ONTAK 63 lixivaptan 63 incyclinide 63 R#/MEM 63 PolyActive ® 63 Firazyr 63 Sutent sunitinib 63 OvaRex 63 trastuzumab Herceptin R 63 Solorel ® 63 URG# 63 Aryplase 63 oncolytic virus therapies 63 NP2 Enkephalin 63 tesetaxel 63 investigational protease inhibitor 63 IND submission 63 Argatroban 63 XP# XP# 63 Prodarsan R 63 oral gallium 63 Nycomed GmbH 63 ZK EPO 63 ISENTRESS raltegravir 63 evaluating tivozanib 63 farletuzumab 63 vidofludimus 63 TAFA# 63 ganetespib 63 SARMs 63 selective S#P# receptor agonist 63 docetaxel Taxotere R 63 cyclophilin inhibitor 63 OSMOPREP 63 Ceflatonin R 63 Erbitux cetuximab 63 EndoTAG 63 Ixempra 63 adecatumumab MT# 63 balsalazide tablet 63 INTEGRILIN R eptifibatide Injection 63 Achieves Primary Endpoint 63 Dabigatran etexilate 63 orally administered inhibitor 63 pan HDAC inhibitor 63 Phase IIa trials 63 Tofacitinib 63 DP VPA 63 Octreolin 63 BEXXAR 63 ularitide 63 INCB# [001] 63 MabThera rituximab 63 Abstral ™ 63 elotuzumab 63 Amrubicin 63 Trobalt 63 cathepsin K inhibitor 63 ApoB SNALP 63 BRILINTA 63 LEVADEX TM 63 LEX System 63 elvucitabine 63 Lupuzor 63 phase IIa clinical 63 marketed pegylated interferons 63 RhuDex ® 63 Bioral Amphotericin B 63 Campath ® 63 methylnaltrexone 63 patented Bioral 63 Alvesco R 63 Anticalins R 63 receptor tyrosine kinase inhibitor 63 preclinically 63 Firazyr ® 63 Hectorol R 63 Capesaris 63 Ridaforolimus 63 ATIR ™ 63 miconazole Lauriad R 63 aleglitazar 63 Cloretazine ® 63 velafermin 63 epigenetic therapies 63 HEPLISAV ™ 63 Evoltra 63 Alexza Staccato 63 PolyActive 63 Pimavanserin 63 Liprotamase 63 HepeX B TM 63 Gemin X 63 FluINsure 63 GTC recombinant human 63 vitro ADME 63 RIGScan CR 63 Liprostin 63 Eligen ® Technology 63 talactoferrin 63 predictive biomarkers 63 delivery polymer matrix 63 LentiVector technology 63 ESTRASORB 63 OMAPRO ™ 63 ELND-#/AZD-# 63 candidate EFAPROXYN TM 63 DermaPrep 63 Tarmogen 63 Saxagliptin 63 allosteric modulator 63 entinostat 63 Zebinix R 63 Aurora kinase inhibitor 63 budesonide foam 63 WILEX 63 GED aPC 63 CEQ# 63 Aloxi R 63 oncolytics 63 Onalta TM 63 Xeloda ® 63 NanoEmulsion 63 IMiD 63 FM VP4 63 VDAs 63 drug GAP #B# 63 Phase III Clinical Trials 63 DUROS 63 zileuton CR 63 Sunovion 63 Exherin 63 oral deforolimus 63 Lymphoseek ® 63 Pancreate 63 Zemiva TM 63 HQK 63 Pafuramidine 63 Voraxaze 63 novel therapeutic antibodies 63 MAA submission 63 NEXTERONE 63 Cerashield 63 Initiates Enrollment 63 recombinant factor VIIa 63 Ipsen Euronext IPN 63 Neovastat 63 Sanctura XR 63 Solasia 63 Phase Ib II 63 CD# CEA 63 GVAX ® 63 IRX 2 63 defensin mimetic antibiotic 63 PORxin TM 63 proprietary PEGylation 63 registrational 63 dextofisopam 63 isavuconazole 63 Arikace 63 formerly LymphoStat B 63 rasagiline tablets 63 Anturol TM 63 IMiDs ® 63 Azixa 63 TRX1 63 ATryn ® 63 cystinosis patients 63 pitavastatin 63 Afatinib 63 Zenvia ™ 63 NEUGENE R 63 OGeS 63 ALN HTT 63 trastuzumab emtansine T DM1 63 Synavive ™ 63 Maribavir 63 MYDICAR ® 63 Nektar PEGylation technology 63 TG# [003] 63 SPRIX ® 63 TKB# 63 Oracea TM 63 candidates Azedra TM 63 oral immunomodulatory 63 synthetic peptide containing 63 JOULFERON 63 Relieva 63 vaccines oncolytic virus 63 COLAZAL R 63 midstage studies 63 inhaled AAT 63 NNR Therapeutics 63 Litx 63 preclinical efficacy 63 Prodarsan ® 63 Hyphanox 63 Memryte 63 DermaVir Patch 63 Solulin 63 Viprinex TM 63 Soliris eculizumab 63 Receives Approvable Letter 63 paclitaxel Taxol ® 63 Completes Patient Enrollment 63 Kevetrin ™ 63 XmAb 63 cMET 63 Laquinimod 63 nalbuphine ER 63 TRANSDUR Sufentanil 63 OncoVex 63 Viprinex 63 Valtropin 63 Glufosfamide 63 HuLuc# 63 Actemra tocilizumab 63 XL# XL# 63 Soriatane 63 Tyrima 63 novel antibody therapeutics 63 developing TB4 63 GlaxoSmithKline Tykerb 63 BRAF inhibitor 62 histone deacetylase HDAC 62 Hedgehog antagonist 62 Urokinase 62 biosurgical 62 OMAPRO 62 LE SN# 62 Anturol ® 62 antiangiogenic agents 62 VaxImmune 62 ABRAXANE ® 62 nonclinical studies 62 Plenaxis TM 62 OMP #M# 62 Tekturna HCT 62 Rezular 62 BrachySil ™ 62 IAP inhibitors 62 INTELLITAB TM 62 Plexxikon proprietary 62 Rhucin ® recombinant 62 NitroMist 62 regorafenib 62 HIV integrase inhibitor 62 PRTX 62 Squalamine 62 SAR# [004] 62 topical NSAID 62 ZADAXIN ® 62 Veronate 62 synthetic retinoid 62 Glufast 62 Frova ® 62 Zoraxel 62 Selective Electrochemical Tumor Ablation 62 Phase IIb III 62 candidates Azedra 62 PSN# [001] 62 Vertex hepatitis C 62 KemPharm 62 GVAX cancer 62 ATL# [001] 62 BiovaxID TM 62 StemEx 62 optimal dosing regimens 62 OncoVEX GM CSF 62 sitaxsentan 62 Tracleer r 62 triphendiol 62 Tezampanel 62 Captisol 62 orally inhaled migraine 62 ATL# [002] 62 TransVax tm 62 Vascular Wrap TM 62 forodesine hydrochloride 62 Sulonex TM 62 sapacitabine CYC# 62 SUMAVEL 62 DCVax ® Brain 62 Dual Opioid TM 62 IoGen 62 Proxinium TM 62 Kissei Pharmaceutical 62 SUTENT ® 62 Spiegelmer 62 Ketotransdel TM 62 anticancer compounds 62 targeted antifolate 62 Prednisporin 62 INTEGRILIN ® 62 NEBIDO 62 ASONEP 62 TRANSDUR Bupivacaine 62 LNP formulations 62 non nucleoside 62 Olmesartan 62 bicifadine 62 ABILIFY ® 62 Bayer Onyx 62 immunosuppressant therapies 62 AzaSite TM 62 RECOTHROM ® 62 OTCBB PYTO 62 PecFent 62 elbion 62 Anticalin ® 62 GRN# 62 IMC #B 62 epothilones 62 acting muscarinic antagonist 62 platforms GVAX 62 cannabinor 62 KRN# 62 RezularTM 62 ZEFTERA TM Zevtera TM 62 Ostabolin C 62 molecular imaging radiopharmaceuticals 62 recombinant biopharmaceutical 62 Alferon N 62 ADME properties 62 SNALP 62 NASDAQ FLML 62 Exenatide LAR 62 markets HP Acthar 62 Aganocide ® 62 antiinfective 62 RPL# 62 Duromist ™ 62 XmAb ® 62 TARIS 62 pemetrexed Alimta 62 TRISENOX R 62 Dual Opioid 62 Inc. AMEX YMI 62 Inhalation Solution 62 Syntonix 62 AZILECT R 62 SERMs 62 Catena ® 62 afamelanotide 62 proprietary intranasal insulin 62 NVA# 62 Altastaph 62 Omnitarg 62 ARIKACE ™ 62 biologic therapeutics 62 proven DuraSite ® 62 APTIMA HPV assay 62 cetuximab Erbitux R 62 PEGylated interferon 62 phase III isavuconazole 62 novel anticancer 62 romidepsin 62 Multiferon R 62 antisense drug 62 HuMax EGFr 62 ciprofloxacin hydrochloride 62 Xcellerated T Cells 62 PharmFilm ® 62 ixabepilone 62 cytotoxics 62 Tesmilifene 62 polysaccharide polymer 62 non peptidic protease 62 PDX pralatrexate 62 renin inhibitors 62 Meets Primary Endpoint 62 DXL TM 62 FIRMAGON R 62 doxercalciferol 62 USL# 62 PROMACTA ® 62 Cellegesic 62 Ceflatonin 62 Nasdaq ENZN 62 ESBA# 62 Initiates Clinical Trial 62 AERx ® 62 EpiCept NP 1 62 MyVax ® 62 Deferiprone 62 platinum chemotherapeutic 62 Amlodipine Besylate 62 CAPHOSOL R 62 PROVENGE sipuleucel T 62 M Enoxaparin 62 BioSTAR R 62 Epothilones 62 BYETTA ® 62 GSK# [002] 62 rhThrombin 62 polymerase inhibitor 62 oral methylnaltrexone 62 Ketotransdel 62 Immunotherapeutic 62 Troxatyl TM 62 immunotherapeutic agent 62 investigational HCV polymerase 62 OnDose 62 MBP# dirucotide 62 NasdaqGM SPPI 62 SANVAR 62 phase IIb III 62 novel emulsion formulation 62 TKM ApoB 62 XmAb# 62 Phase III confirmatory 62 Solazed 62 Varespladib 62 Crofelemer budesonide foam 62 Fentanyl TAIFUN R 62 Alzhemed TM 62 XL# anticancer compounds 62 Amigal 62 BCR ABL inhibitor 62 Veregen TM 62 Reverset 62 Striant 62 Genentech Roche 62 POSIDUR TM 62 vaginally administered lidocaine 62 Canvaxin TM 62 Vilazodone 62 punctal plug delivery 62 dasatinib Sprycel 62 Initiates Clinical 62 PEGylation technology 62 thalidomide Thalomid 62 TLR9 agonist 62 Helsinn Healthcare 62 Onrigin 62 topical anti infective 62 PN# [001] 62 Phase III Clinical Trial 62 orally bioavailable 62 oral PTH 62 Ciclesonide 62 unoprostone isopropyl 62 tramiprosate 62 Tekamlo 62 Zybrestat 62 Dynepo 62 Indaflex TM 62 ponatinib 62 CytoFabTM 62 Muraglitazar 62 NYSE AMEX PLX 62 Safinamide 62 TH# [003] 62 endothelin antagonist 62 Gastrotech 62 AVE# 62 novel anti infective 62 Fc fusion protein 62 immunotherapeutics 62 HuMax CD# 62 Dalbavancin 62 APC Targeting Technology 62 Reports Preclinical Data 62 ThermoDox R 62 Nasdaq RDEA 62 ALK inhibitors 62 Harbor BioSciences 62 Glybera R 62 Intravenous Human 62 NanoCrystal technology 62 TRANSDUR ™ 62 TRO# 62 StromaCel 62 CD# monoclonal antibody 62 EndoTAG TM -1 62 Bicifadine 62 fluoroquinolone antibiotic 62 Benlysta belimumab 62 atacicept 62 dermatology biopharmaceutical company 62 selective androgen receptor modulator 62 Huntexil 62 otelixizumab 62 Accelerated Intelligent 62 interferon gamma 1b 62 Anthim 62 allogeneic cell 62 RGB # 62 Augment TM 62 Valdoxan 62 fostamatinib 62 SCIB1 62 IV APAP 62 Multiferon 62 novel peptides 62 dirucotide 62 TRANSDUR ® 62 mitogen activated ERK kinase 62 small molecule tyrosine 62 commercializing anti infective 62 Pentad TM 62 liposomal formulations 62 refractory gout 62 Egrifta 62 palifosfamide Zymafos TM 62 Enhanze Technology 62 MAXY alpha 62 cediranib 62 phase IIb 62 VIR# 62 arsenic trioxide injection 62 Loramyc TM 62 Zerenex ™ 62 ELIQUIS 62 Orally administered 62 ® bortezomib 62 oral Factor Xa 62 ISTODAX 62 fidaxomicin Phase 62 Somatuline R Autogel R 62 riociguat 62 InvaGen 62 Initiates Clinical Trials 62 delivers fluocinolone acetonide FA 62 ocular formulation 62 dalbavancin 62 Campath alemtuzumab 62 ionotropic glutamate receptor antagonists 62 intravenous methylnaltrexone 62 Xeloda capecitabine 62 BLA filing 62 BAY #-# 62 pain palliation 62 Panzem NCD 62 vapreotide acetate 62 Keppra XR 62 Stapled Peptide 62 orally dosed 62 Removab 62 zileuton 62 panitumumab Vectibix 62 EOquin TM 62 TLR agonists 62 Aphthasol R 62 DermTech International 62 ClearPath TM 62 radiotherapeutic 62 treat refractory angina 62 topical antifungal 62 BioSilicon 62 ZOLINZA 62 Chemokine Therapeutics 62 ZALBIN 62 Amplimexon 62 phase Ib clinical 62 Besivance 61 SynCon 61 registrational trials 61 theranostic 61 Celsion Corporation 61 BAL# [002] 61 Trofex TM 61 JP-#/fipamezole 61 torezolid 61 RELISTOR ® 61 INxin TM 61 Azedra ™ 61 OX1 61 Presents Preclinical 61 urocortin 2 61 Rebif ® 61 multicenter Phase II 61 VIAtab TM 61 renin inhibition 61 Cetuximab Erbitux 61 Photocure 61 Emselex 61 ONCONASE R 61 biased ligand 61 candidate NGX 61 KRYSTEXXA TM pegloticase 61 sirtuin modulators 61 Alequel ™ 61 CCR5 inhibitor 61 ALN TTR# 61 Exelon Patch 61 ProLindac TM 61 Files IND 61 Serdaxin 61 Cloretazine R